Study examines potential of day 7 euploid transfers

Researchers in a 2019 study compared euploid transfer outcomes for day 5, 6 or 7 euploids, finding that day 7 embryos have good potential.

In the lab, an embryo grows in about a week.

After fertilization, the single cell of the egg cleaves to form 2 cells, then 4 cells, then 8 cells.

Thenโ€ฆthe cells start to stick together and eventually a blastocyst forms. Ideally this whole process of becoming a blast takes about 5 days. Sometimes longer.

You hear a lot about day 5 blastocysts. But as far as success rates go, embryos that take 6 days to make a blastocyst (aka a day 6 blastocyst), are comparable in success to day 5: similar euploidy, pregnancy rates, etc.

And then we have the day 7 blasts. These take 7 days to make it to blastocyst.

So how do they do as far as success rates go? Not too bad it turns out โ€“ but many clinics wonโ€™t grow embryos to day 7. Itโ€™s not clear why this is, but it may be because some believe that embryos canโ€™t be cultured past day 6 because they degenerate (die), or because they have very low success rates and just arenโ€™t worth it.

Whatever the case โ€“ embryos cultured to day 7 do have a chance, and the evidence for their use is growing.

Check myย complete guide to PGT-Aย to get more background on PGT-A (akaย PGSย testing).

โš ๏ธ Remembryo summarizes and interprets IVF research for educational purposes. Posts highlight selected findings and may simplify or omit study details, including methods, analyses, author interpretations, limitations, and protocol specifics (such as timing, dosing, or eligibility criteria). These summaries are not a substitute for the original study. Always review the full publication before treatment decisions.

๐Ÿ”— Original studies are referenced in this post or within the linked Remembryo posts.

๐Ÿ’ก Reminder: Terms underlined with a dotted black line are linked to glossary entries. Clicking these does not count toward your paywall limit.

Hernandez-nieto (2019) looked at a total of 25772 blasts from 4136 patients between 2012 to 2018. Among all women of all ages, about 50% of day 5 and day 6 embryos were euploid, with about 40% of day 7 embryos being euploid. Thatโ€™s not bad at all!

Those numbers start to drop with increased maternal age which isnโ€™t surprising, from 51.08% at 35 and younger, 37.41% at age 38-40, to 9.46% for women 43 and older.

So what about the success rates for day 7 euploids? After transferring a single euploid, for live birth rates, day 7 euploids came in at about 20% compared to 56%/45% for day 5/day 6. Or roughly half. You can see the outcomes below.

Outcomes following the transfer of a single euploid from day 5, 6 or 7

So how does this relate to the grades of the day 7 embryos?

They used a modified grading system that included A-D instead of the standard A-C. It can be difficult to compare this system with the standard system, but a D is definitely a C and an A is definitely an A. The trouble is figuring out how B and C relate to the standard system.

Regardless, they reported outcomes based on good quality (4BB or higher), moderate quality (4BC or 4CB) and fair quality (4CC) day 7 euploids. There were 68, 28 and 20 transfers, respectively.

So, at least based on this study, day 7 embryos have a pretty good chance of working! Embryos can be grown to day 7 and be biopsied, with fairly high euploidy rates, and decent live birth rates (as high as 25% with good quality day 7s)!

Reference

Hernandez-Nieto C, Lee JA, Slifkin R, Sandler B, Copperman AB, Flisser E. What is the reproductive potential of day 7 euploid embryos? Hum Reprod. 2019 Sep 29;34(9):1697-1706. doi: 10.1093/humrep/dez129. PMID: 31398251.

If you liked this post and want to support what I do, please consider a paid subscription, Patreon or donate through PayPal!

ย 


About Embryoman

Embryoman (Sean Lauber) is a former embryologist and the founder of Remembryo, an IVF research and fertility education website. After working in an IVF lab in the US, he returned to Canada and now focuses on making fertility research more accessible. He holds a Masterโ€™s in Immunology and launched Remembryo in 2018 to help patients and professionals make sense of IVF research. Sean shares weekly study updates on Facebook, Instagram, and Reddit regularly. He also answers questions on Reddit or in his private Facebook group.


ย